These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35594444)
21. [GBA mutations and Parkinson's disease]. Wang DX; Xie JX; Song N Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071 [TBL] [Abstract][Full Text] [Related]
22. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
23. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872 [TBL] [Abstract][Full Text] [Related]
24. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254 [TBL] [Abstract][Full Text] [Related]
25. Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice. Johnson ME; Bergkvist L; Stetzik L; Steiner JA; Meyerdirk L; Schulz E; Wolfrum E; Luk KC; Wesson DW; Krainc D; Brundin P Neurobiol Dis; 2021 Nov; 159():105513. PubMed ID: 34536552 [TBL] [Abstract][Full Text] [Related]
27. The association between lysosomal protein glucocerebrosidase and Parkinson's disease. Kong B; Yang T; Gu JW; Kuang YQ; Cheng L; Yang WT; Yang XK; Xia X; Cheng JM; Ma Y; Zhang JH; Yu SX Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):143-51. PubMed ID: 23377801 [TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
29. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice. Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286 [TBL] [Abstract][Full Text] [Related]
30. Involvement of Gaucher Disease Mutations in Parkinson Disease. Vilageliu L; Grinberg D Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692 [TBL] [Abstract][Full Text] [Related]
31. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326 [TBL] [Abstract][Full Text] [Related]
32. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy. von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
34. GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease. Ikuno M; Yamakado H; Akiyama H; Parajuli LK; Taguchi K; Hara J; Uemura N; Hatanaka Y; Higaki K; Ohno K; Tanaka M; Koike M; Hirabayashi Y; Takahashi R Hum Mol Genet; 2019 Jun; 28(11):1894-1904. PubMed ID: 30689867 [TBL] [Abstract][Full Text] [Related]